PlainVitamins

Andrographis Extract 400 mg

by Protocol For Life Balance · capsule · 90 veg capsules

  • On the market (NIH)
  • UPC 7 07359 14591 7
  • DSLD label 258626
  • Serving 1 capsule
  • 90 servings

Andrographis Extract 400 mg by Protocol For Life Balance lists one ingredient: 400 mg of andrographis extract per serving of 1 capsule. Its current label entered the NIH Dietary Supplement Label Database on January 22, 2022.

What is in Andrographis Extract 400 mg?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Andrographis Extract 400 mg: Supplement Facts rows against the market (DSLD label 258626, January 2026 release)
IngredientAmount% DVAmong products listing it
Andrographis extractas Andrographolides400 mgAndrographis in Andrographis Extract 400 mg against 213 products400 mg per serving; the middle half of products list 100 mg to 400 mg, the median 200 mg.400 mg

Higher than 75% of 213 products listing andrographis (median 200 mg). Per day at the most servings: 1,200 mg.

Source: NIH ODS Dietary Supplement Label Database, label 258626 (entered January 22, 2022), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 to 3 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested usage: Take 1 capsule 2 to 3 times daily as needed, or as directed by your healthcare practitioner.
Warnings
Causes/Interactions: Consult your healthcare practitioner if pregnant/nursing, taking medication, or have a medical condition.
Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish, shellfish, tree nut or sesame ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.
Allergens and what it does not contain
Non-GMO
Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish, shellfish, tree nut or sesame ingredients.

Source: label statements in DSLD label 258626.

What else is on the label?

Other ingredients: Hypromellose, Rice Flour, Stearic Acid, Silicon Dioxide.

How many labels does Andrographis Extract 400 mg have?

One label is on file, entered on January 22, 2022.

  1. Label 258626 (current) Entered January 22, 2022 · on the market · 90 veg capsules · UPC 7 07359 14591 7

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Protocol For Life Balance (manufacturer, distributor), Bloomingdale, IL. All Protocol For Life Balance products.

Where next?